Novel multiomics tumor profiling demonstrates feasibility and clinical benefit in guiding melanoma treatment decisions, a ...

Teddi Mellencamp stressed the importance of being an advocate for your own health after learning her melanoma progressed to ...

The combination of RPI, a genetically engineered herpes simplex virus type 1, and Opdivo shrank both injected and non-injected tumors by 30%.

Dr. Vincent Ma discussed the most recent and notable treatment updates for patients with high-risk and advanced melanoma.

A new treatment for advanced melanoma is showing promising results for people whose tumors have stopped responding to existing therapies.

Median progression-free survival was 3.7 months, with 44.4% of patients being progression free at 6 months and 32.3% at 12 ...

Neoadjuvant cobolimab and dostarlimab followed by surgery and adjuvant dostarlimab may confer benefits over perioperative pembrolizumab in patients with high-risk, resectable melanoma.

Focal nodular hyperplasia (FNH): A benign liver lesion characterised by disorganised hepatocyte proliferation, typically diagnosed via imaging, with minimal risk of malignant conversion.

Researchers have discovered that the most aggressive melanomas, the deadliest form of skin cancer, overactivate two key processes in mitochondria, the components of cells that provide energy ...

Nemolizumab significantly and safely improved itch and skin lesions for up to 2 years in patients with moderate to severe prurigo nodularis.

The symtoms of nodular melanoma have been explained after a doctor shared a video of 'worst melanoma’ he's ever seen.